SCL
STEPAN CO
NYSE · Basic Materials · Chemicals - Specialty · US
$70.17
+2.20%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.5B | 2.3B | 2.2B | 2.3B | 2.8B |
| Cost of Revenue | 2.2B | 2.1B | 1.9B | 2.0B | 2.3B |
| Gross Profit | 303.9M | 269.9M | 272.2M | 277.6M | 427.1M |
| Operating Expenses | |||||
| R&D Expense | 63.6M | 59.3M | 55.7M | 59.0M | 66.6M |
| SG&A Expense | 147.3M | 139.6M | 143.9M | 141.6M | 161.2M |
| General & Admin Expense | 95.8M | 90.8M | 98.3M | 93.2M | 102.2M |
| Selling & Marketing Expense | 51.5M | 48.8M | 45.6M | 48.4M | 59.0M |
| Other Expenses | 7.6M | 1.7M | 2.2M | 18.4M | (8.1M) |
| Total Operating Expenses | 218.5M | 200.5M | 201.7M | 219.0M | 219.7M |
| Cost and Expenses | 2.4B | 2.3B | 2.1B | 2.3B | 2.6B |
| Operating Income (EBIT) | 85.4M | 69.4M | 70.5M | 58.6M | 207.3M |
| Non-Operating | |||||
| Interest Income | — | 4.1M | 5.3M | 3.8M | 1.1M |
| Interest Expense | 17.0M | 26.2M | 19.5M | 15.9M | 10.9M |
| Net Interest Income | (17.0M) | (22.1M) | (14.2M) | (12.1M) | (9.8M) |
| Other Non-Op Income/Expense | (82.6M) | (9.5M) | (10.0M) | (10.2M) | (18.6M) |
| Non-Operating Income (excl Interest) | 52.4M | (16.8M) | (9.4M) | (5.7M) | 7.7M |
| EBT (Pre-Tax Income) | 2.8M | 59.9M | 60.4M | 48.4M | 188.7M |
| Income Tax Expense | (1.5M) | 13.0M | 10.1M | 8.2M | 41.5M |
| Bottom Line | |||||
| Net Income | 4.3M | 46.9M | 50.4M | 40.2M | 147.2M |
| Earnings from Cont. Ops | 4.3M | 46.9M | 50.4M | 40.2M | 147.2M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 4.3M | 46.9M | 50.4M | 40.2M | 147.2M |
| Per Share | |||||
| Basic EPS | $0.19 | $2.05 | $2.21 | $1.77 | $6.46 |
| Diluted EPS | $0.19 | $2.05 | $2.20 | $1.75 | $6.38 |
| Revenue Per Share | $110.65 | $101.96 | $95.23 | $102.11 | $121.74 |
| Shares | |||||
| Basic Shares Outstanding | 22.9M | 22.9M | 22.9M | 22.8M | 22.8M |
| Diluted Shares Outstanding | 23.0M | 22.9M | 22.9M | 22.9M | 23.1M |
| Profitability Metrics | |||||
| EBITDA | 160.9M | 212.2M | 192.1M | 169.7M | 294.2M |
| D&A | 127.9M | 126.0M | 112.2M | 105.3M | 94.7M |
| EBIT | 33.0M | 86.1M | 79.9M | 64.3M | 199.6M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026